Patents Assigned to NUBIOME, INC.
-
Patent number: 11083746Abstract: Method for immobilizing a target microorganism or target chemical found in a mammal includes introducing into a gastrointestinal tract of the mammal immobilization particles including immobilization molecules capable of attaching to the target microorganism or the target chemical, which immobilization molecules are attached to one or more portions of a structure that is capable of inhibiting contact between tissues of the gastrointestinal tract and the target microorganisms or target chemicals attached to the immobilization molecules.Type: GrantFiled: March 29, 2019Date of Patent: August 10, 2021Assignee: NuBiome, Inc.Inventor: Brian C. Lue
-
Patent number: 10617727Abstract: An embodiment is a method of mitigating or treating Gastroesophageal Reflux Disease (GERD) caused by a neurological disorder that includes administering an effective amount of a medicament that includes a supernatant resulting from culturing Lactobacillus bulgaricus B-30892 bacteria to a human to mitigate or treat GERD caused by a neurological disorder.Type: GrantFiled: February 15, 2018Date of Patent: April 14, 2020Assignee: NuBiome, Inc.Inventor: Brian C. Lue
-
Patent number: 10363279Abstract: An embodiment is a method of preventing, mitigating or treating neurological conditions and diseases that includes administering an effective amount of a medicament comprised of Lactobacillus bulgaricus B-30892 and/or a supernatant resulting from culturing Lactobacillus bulgaricus B-30892 and/or bioactive materials resulting from culturing Lactobacillus bulgaricus B-30892 to a human to prevent, mitigate or treat neurological conditions and diseases.Type: GrantFiled: February 17, 2017Date of Patent: July 30, 2019Assignee: NuBiome, Inc.Inventor: Brian C. Lue
-
Patent number: 10245279Abstract: Method for immobilizing a target microorganism or target chemical found in a mammal includes introducing into a gastrointestinal tract of the mammal immobilization particles including immobilization molecules capable of attaching to the target microorganism or the target chemical, which immobilization molecules are attached to one or more portions of a structure that is capable of inhibiting contact between tissues of the gastrointestinal tract and the target microorganisms or target chemicals attached to the immobilization molecules.Type: GrantFiled: January 20, 2016Date of Patent: April 2, 2019Assignee: NuBiome, Inc.Inventor: Brian C. Lue
-
Patent number: 10245289Abstract: An embodiment is a method of preventing, mitigating or treating Lupus that includes administering an effective amount of a medicament to a human comprised of Lactobacillus bulgaricus B-30892 and/or a supernatant resulting from culturing Lactobacillus bulgaricus B-30892 and/or bioactive materials resulting from culturing Lactobacillus bulgaricus B-30892 to prevent, mitigate or treat Lupus.Type: GrantFiled: December 14, 2016Date of Patent: April 2, 2019Assignee: NuBiome, Inc.Inventor: Brian C. Lue
-
Patent number: 10077128Abstract: One embodiment is a shrink labeler for use to shrink a shrink label onto a bottle including: a containment wall having a gas/steam inlet; and a showerhead container capable of holding the bottle in close proximity to orifices disposed therein and having an aperture through which the bottle may be introduced thereinto; wherein the gas/steam inlet is coupled to a plenum disposed between the containment wall and the showerhead container.Type: GrantFiled: February 10, 2017Date of Patent: September 18, 2018Assignee: NuBiome, Inc.Inventor: Brian C. Lue
-
Patent number: 9925225Abstract: An embodiment is a method of preventing, mitigating or treating Gastroesophageal Reflux Disease (GERD) that includes administering an effective amount of a medicament comprised of the Lactobacillus bulgaricus B-30892 strain and/or bioactive compounds from its supernatant to a human to prevent, mitigate or treat GERD.Type: GrantFiled: September 24, 2015Date of Patent: March 27, 2018Assignee: NuBiome, Inc.Inventor: Brian C. Lue
-
Patent number: 8927242Abstract: An embodiment is a method of preventing, mitigating or treating Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) that includes administering an effective amount of a medicament comprised of Streptococcus oralis 89a to a human to prevent, mitigate or treat PANDAS.Type: GrantFiled: May 3, 2013Date of Patent: January 6, 2015Assignee: NuBiome, Inc.Inventors: Brian C. Lue, Fredrick C. Westall
-
Publication number: 20130302296Abstract: An embodiment is a method of preventing, mitigating or treating Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) that includes administering an effective amount of a medicament comprised of Streptococcus oralis 89a to a human to prevent, mitigate or treat PANDAS.Type: ApplicationFiled: May 3, 2013Publication date: November 14, 2013Applicant: NuBiome, Inc.Inventors: Brian C. Lue, Fredrick C. Westall
-
Publication number: 20120108787Abstract: An immobilization particle for immobilizing a target microorganism or target chemical found in or on a mammal that includes: immobilization molecules capable of attaching to a target microorganism or a target chemical, which immobilization molecules are attached to one or more portions of a substrate structure; wherein the substrate structure is capable of inhibiting contact between tissues of the mammal and target microorganisms or target chemicals attached to immobilization molecules attached to the one or more portions.Type: ApplicationFiled: January 5, 2012Publication date: May 3, 2012Applicant: NUBIOME, INC.Inventor: Brian C. Lue
-
Publication number: 20110081320Abstract: An embodiment entails administering an effective amount of a product such as a protease or a source of a protease that destroys or deactivates an immunogen, mimic or antigen specific to a particular autoimmune disease before it encounters the immune system of a patient.Type: ApplicationFiled: October 5, 2010Publication date: April 7, 2011Applicant: NUBIOME, INC.Inventors: Fredrick C. Westall, Richard Blankenbecler, Brian C. Lue